Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypocalcemic syndromes.

F Carlstedt1, L Lind

  • 1Department of Medical Science, Uppsala University, Uppsala, Sweden. fredrik.carlstedt@post.utfors.se

Critical Care Clinics
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolome-wide association study identifies metabolites associated with human exposure to perfluoroalkyl substances.

Journal of exposure science & environmental epidemiology·2026
Same author

An interpretable molecular descriptor for machine learning predictions in atmospheric science.

The Journal of chemical physics·2026
Same author

Longitudinal and cross-sectional analysis of perfluoroalkyl substances and kidney function.

Journal of exposure science & environmental epidemiology·2025
Same author

Risk of venous thromboembolism in relation to high physical activity level in men over 27 year follow up.

Journal of thrombosis and thrombolysis·2024
Same author

Plasma perfluoroalkyls are associated with decreased levels of proteomic inflammatory markers in a cross-sectional study of an elderly population.

Environment international·2020
Same author

Using proximity extension proteomics assay to discover novel biomarkers associated with circulating leptin levels in patients with type 2 diabetes.

Scientific reports·2020
Same journal

Critical Care and Contagion: Evolving Frontiers of Infectious Diseases in the Modern Intensive Care Unit.

Critical care clinics·2026
Same journal

Advances and Challenges in Sepsis Care in Low-Resource Settings.

Critical care clinics·2026
Same journal

The Respiratory Triple Pandemic in the Intensive Care Unit: Epidemiology, Clinical Features and Management of COVID-19, Influenza and Respiratory Syncytial Virus.

Critical care clinics·2026
Same journal

Antibiotic Stewardship for the Intensivist.

Critical care clinics·2026
Same journal

Infection Prevention and Control in the Intensive Care Unit.

Critical care clinics·2026
Same journal

Antibiotic Considerations in the Critically Ill: Empiric Choices and Dosing.

Critical care clinics·2026
See all related articles

Hypocalcemia, or low calcium levels, is common in intensive care units (ICUs) and linked to worse outcomes. The study suggests current evidence is insufficient to recommend routine calcium supplementation for these critically ill patients.

Area of Science:

  • Critical Care Medicine
  • Endocrinology
  • Nephrology

Background:

  • Hypocalcemia is a frequent complication in intensive care unit (ICU) patients, often indicating a poor prognosis.
  • Potential mechanisms include fluid shifts, increased calcium binding, intracellular calcium excess, and dysregulated parathyroid hormone (PTH) secretion.
  • A link between hypocalcemia, altered PTH secretion, and systemic inflammation is observed, but its clinical significance remains unclear.

Purpose of the Study:

  • To investigate the relationship between systemic inflammation and hypocalcemia with altered parathyroid hormone secretion in ICU patients.
  • To determine if the observed PTH response during hypocalcemia in critical illness is physiologically appropriate.
  • To evaluate the current evidence base for recommending general calcium supplementation in ICU patients with hypocalcemia.

Related Experiment Videos

Main Methods:

  • Review of existing literature on hypocalcemia, parathyroid hormone dynamics, and systemic inflammation in the ICU.
  • Analysis of proposed mechanisms contributing to low calcium levels in critical illness.
  • Evaluation of the appropriateness of PTH secretion in response to hypocalcemia in the context of inflammation.

Main Results:

  • Hypocalcemia is prevalent in ICUs and associated with adverse patient outcomes.
  • Multiple factors contribute to hypocalcemia, including fluid management, chelation, cellular calcium uptake, and PTH regulation.
  • The precise role and appropriateness of PTH secretion in the context of systemic inflammation and hypocalcemia require further investigation.

Conclusions:

  • The current understanding of the interplay between systemic inflammation, hypocalcemia, and PTH secretion in ICU patients is incomplete.
  • Routine calcium supplementation cannot be universally recommended for ICU patients with hypocalcemia due to insufficient evidence.
  • Further research is needed to clarify the adaptive significance of PTH responses in critical illness-induced hypocalcemia.